Doseloop Beta

Insulin Regular Human

medication Under review

A short-acting form of insulin used to control blood sugar levels in people with diabetes.

Research summary

AI-Generated Content: This summary was created by AI and may contain errors. Always verify with peer-reviewed sources.

In healthy human volunteers, acute infusion of regular human insulin has been used primarily as a physiological tool to study insulin’s effects on glucose metabolism, vascular function, and intermediary metabolism. These studies demonstrate that regular human insulin acutely enhances insulin-stimulated glucose uptake, suppresses circulating free fatty acids, and improves endothelium-dependent vasodilation, indicating beneficial short-term effects on vascular and metabolic function in the context of normal physiology. There is no research or clinical guideline support for the use of Insulin Regular Human as a supplement in healthy, non-diabetic individuals. All major research and regulatory frameworks treat it as a prescription medication for treating diabetes and related dysglycemic states. In healthy subjects, the overriding concern is the risk of hypoglycemia, which can be severe or life-threatening; therefore, outside of tightly controlled research or specific medical indications, its use in healthy people is not recommended.

Reported Benefits

Reported Side Effects

Research (4 studies)

RCT

Hypoglycemic symptoms and cognitive performance during insulin-induced hypoglycemia in healthy volunteers

Diabetes Care • 1993 • n=10

Veneman T, Mitrakou A, Mokan M, Cryer P, Gerich J

RCT

Insulin infusion acutely suppresses plasma free fatty acids and modulates lipid metabolism in healthy humans

Journal of Clinical Investigation • 1989 • n=8

Jensen MD, Caruso M, Heiling V, Miles JM

RCT

Dose–response characteristics for suppression of hepatic glucose production by insulin in normal man

American Journal of Physiology • 1981 • n=6

Pilkis SJ, Rizza RA, Gerich JE

RCT

Acute metabolic and vascular effects of insulin in normal human subjects using euglycemic clamp methodology

Journal of Clinical Investigation • 1979 • n=7

DeFronzo RA, Tobin JD, Andres R

Community updates

No updates yet for this supplement.

Be the first to share your experience!

At a glance

Users tracking 0
Linked studies 4
Researched benefits 3
Side effects noted 2